To Top

Archives for: October 29th, 2020

NORD CEO Affirms Science Should Guide FDA’s Work

Written by Valaree DonFrancesco on August 25, 2020
“Since 1906, FDA’s dedicated career employees have worked tirelessly to ensure that Americans have access to the safest supply of products we rely on every day, including food, drugs and medical devices. As a result, the US regulatory system sets the gold standard for the rest of the world. FDA’s… Read More

NORD Issues Statement on Recently Introduced “Promising Pathway Act”

Written by Laura Mullen on June 26, 2020

NORD is deeply concerned about the “Promising Pathway Act” recently introduced in both the Senate and the House. Contrary to the stated goal of giving patients with serious and life-threatening diseases a “chance at receiving meaningful treatments,” this legislation, by its own terms, would lower FDA’s approval standards, exposing patients… Read More